Published on in Vol 26 (2024)

This is a member publication of University College London (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50855, first published .
Digital Self-Management Platform for Adult Asthma: Randomized Attention-Placebo Controlled Trial

Digital Self-Management Platform for Adult Asthma: Randomized Attention-Placebo Controlled Trial

Digital Self-Management Platform for Adult Asthma: Randomized Attention-Placebo Controlled Trial

Journals

  1. Alladina J, Moschovis P, Gandhi H, Carstens D, Bacci E, Cutts K, Coyne K, Goldsborough K, Jiang D, O’Brien C, Bernard Kinane T. Observational study of the Amaze™ asthma disease management platform. DIGITAL HEALTH 2024;10 View
  2. Hietbrink E, Middelweerd A, d’Hollosy W, Schrijver L, Laverman G, Vollenbroek-Hutten M. Exploring the Acceptance of Just-in-Time Adaptive Lifestyle Support for People With Type 2 Diabetes: Qualitative Acceptability Study. JMIR Formative Research 2025;9:e65026 View
  3. Nikolov P, Petrova G. Technological and digital innovations in improving adherence to asthma medication therapy. Pharmacia 2025;72:1 View